TRY FOR FREE
BIOMARKERBASE

The Leading Solution for Biomarker Intelligence

BiomarkerBase is focused on leveraging sophisticated machine learning techniques to read public sources of information and collect, analyze and categorize the world’s biomarker knowledge. We use these algorithms to draw conclusions about the usefulness of biomarkers to your programs as described in the published literature and to determine whether or not the biomarker is measured (as opposed to just mentioned). That allows us to deliver to you the most relevant evidence for setting effective biomarker strategies with efficiency.

Amplion’s pharmaceutical and diagnostic clients have accelerated their biomarker- associated research by 50% or more and increased clinical program success rates by up to 3x over previous methods.


GET A DEMO


BiomarkerBase™ is a web-based, self-service biomarker intelligence solution providing a comprehensive landscape of clinical biomarker usage and emerging or novel biomarkers. Biomarkerbase keeps your focus on the most evidence-based, well-validated and commercially viable opportunities.

Providing insights into:

  • Pharma and industry program landscape
  • Biomarker test and provider landscape
  • Recommendations of the most relevant biomarkers for a portfolio’s strategy
  • Biomarker measurement in clinical trials and literature
  • Research supporting / contradicting biomarker usage
  • Recommendations of the most relevant biomarkers for a program’s strategy
  • Research supporting / contradicting biomarkers and disease correlation
  • Biomarkers that correspond to a drug’s MOA and Pathways
  • Availability of biomarker tests and providers

Uncovering Innovation is Hard Missing Critical Evidence is Easy

With over 1.2M new publications each year and exponential growth in biomarker research it’s impossible to keep up. Uncovering novel, emerging biomarkers to drive innovation is incredibly difficult. Eliminating blind spots in your biomarker strategies is challenging without leveraging a machine learning powered approach.

Amplion’s BiomarkerBase efficiently delivers the biomarker intelligence you need for a comprehensive biomarker strategy that will drive the success of your programs.

GET A DEMO

CUSTOMER SUCCESS
CUSTOMER SUCCESS STORIES
amplion-biomarkerbase-engine.gif

Amplion’s BiomarkerBase Benefits

  • LITERATURE PRIORITIZATION:Triage the research that supports or contradicts your hypothesis to set the right strategies for your program.
  • BIOMARKER USAGE:Ensure that the biomarkers in your strategy are used in a way best supported by clinical evidence from trial activity.
  • CONSOLIDATED INFORMATION:Gain instant insights from dozens of evidence sources into the clinical and pre-clinical research that will improve the likelihood of success for your programs.
  • NORMALIZED SYNONYMS:Amplion has invested thousands of person-hours to develop the most comprehensive biomarker synonyms on the market. BiomarkerBase unifies all of those synonyms into a single record to avoid missing key evidence.

BiomarkerBase Is Available As

solutions-for-pharma-icon.png

SELF SERVICE

Access a web-based SaaS solution with robust search and reporting capability.

> TRY IT FOR FREE

biomarkerbase-api-icon.png

API

Integrate BiomarkerBase’s intelligence into your analytics platforms or custom applications.

> TRY IT FOR FREE

solutions-for-diagnostics.png

BIOMARKER STRATEGY REPORTS

Leverage our team of experts to build Strategic Biomarker Plans for your programs.

> LEARN MORE